ACOU085 for Hearing Loss Prevention in Testicular Cancer Patients Receiving Cisplatin

Clinical trial NCT06521190 · UNKNOWN

Trial details

NCT number: NCT06521190
Sponsor: Acousia Therapeutics GmbH
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Cisplatin-induced Hearing Loss

Start date: 2023-12-15
Primary completion: 2025-03-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.